AU7920198A - Intratumoral administration of triphenylethylenes for the treatment of cancer - Google Patents

Intratumoral administration of triphenylethylenes for the treatment of cancer

Info

Publication number
AU7920198A
AU7920198A AU79201/98A AU7920198A AU7920198A AU 7920198 A AU7920198 A AU 7920198A AU 79201/98 A AU79201/98 A AU 79201/98A AU 7920198 A AU7920198 A AU 7920198A AU 7920198 A AU7920198 A AU 7920198A
Authority
AU
Australia
Prior art keywords
triphenylethylenes
cancer
treatment
intratumoral administration
intratumoral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79201/98A
Inventor
Kaija Af Ursin
Michael Degregorio
Lauri Kangas
Juha Kiesvaara
Kauko Kurkela
Tapani Vaha-Vahe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Oyj filed Critical Orion Oyj
Publication of AU7920198A publication Critical patent/AU7920198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
AU79201/98A 1997-06-19 1998-06-18 Intratumoral administration of triphenylethylenes for the treatment of cancer Abandoned AU7920198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87925297A 1997-06-19 1997-06-19
US879252 1997-06-19
PCT/FI1998/000543 WO1998058634A2 (en) 1997-06-19 1998-06-18 Intratumoral administration of triphenylethylenes for the treatment of cancer

Publications (1)

Publication Number Publication Date
AU7920198A true AU7920198A (en) 1999-01-04

Family

ID=25373740

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79201/98A Abandoned AU7920198A (en) 1997-06-19 1998-06-18 Intratumoral administration of triphenylethylenes for the treatment of cancer

Country Status (3)

Country Link
AU (1) AU7920198A (en)
WO (1) WO1998058634A2 (en)
ZA (1) ZA984650B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU761435B2 (en) * 1998-05-07 2003-06-05 University Of Tennessee Research Corporation, The A method for chemoprevention of prostate cancer

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410043B1 (en) 1998-05-07 2002-06-25 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6413533B1 (en) 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6632447B1 (en) 1998-05-07 2003-10-14 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
WO2016106146A1 (en) 2014-12-23 2016-06-30 The Regents Of The University Of California Methods for immunomodulation of cancer and infectious disease therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU761435B2 (en) * 1998-05-07 2003-06-05 University Of Tennessee Research Corporation, The A method for chemoprevention of prostate cancer

Also Published As

Publication number Publication date
WO1998058634A2 (en) 1998-12-30
ZA984650B (en) 1998-12-08
WO1998058634A3 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
AU6513298A (en) Therapeutic compositions
AU1403199A (en) Local delivery of therapeutic agents
AU1041599A (en) Therapeutic uses of triazolo-pyridazine derivatives
AU4067697A (en) Therapeutic compositions for treatment of cancer
AU3891299A (en) Combination therapy for treatment of depression
AU2508597A (en) Drug for the treatment of tumours
AU2991299A (en) Monoterpenoid derivatives for treatment of cancer
AU1184399A (en) Therapeutic molecules
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
IL121329A0 (en) A pharmaceutical composition for the treatment of cancer
AU7920198A (en) Intratumoral administration of triphenylethylenes for the treatment of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU1800100A (en) Medicinal preparations
AU1595101A (en) Oncolytic combinations for the treatment of cancer
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU1940800A (en) Combination therapy for the treatment of sepsis
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU4145999A (en) Topical drug for the treatment of viral infections
AU1171099A (en) Therapeutic agents
AU7641098A (en) Therapeutic composition
AU1014997A (en) A drug for the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase